Sponsored by the Innovative Medicines Initiative (IMI) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) under the Horizon 2020 programme, PharmaLedger is a 36 month project that brings together 12 global pharmaceutical companies and 17 public and private entities; including technical, legal, regulatory, academia, research organisations and patient representative organisations.
The goal of the project is to provide a widely trusted platform that supports the design and adoption of blockchain-enabled healthcare solutions while accelerating delivery of innovation that benefits the entire ecosystem, from manufacturers to patients.
Develop a scalable, sustainable, beyond-state-of-the-art blockchain platform
Define and formalise an effective governance for the PharmaLedger framework
Ensure privacy and confidentiality of PharmaLedger data
Perform reference implementation and validation of prioritised business use cases
Develop and integrate a health data marketplace and a collaboration platform
Allow greater access to and security of information across use cases that integrate the use of IOT and medical devices.
Provide a legal and ethical framework to ensure regulatory, legal and data privacy compliance
Involve key healthcare ecosystem stakeholders in the elicitation of requirements and testing of the reference implementation
Generate a comprehensive industry digitisation methodology and document it in a manual for small, medium and large industry players and provide a set of new patients’ engagement processes for supply and consumption of health data